According to a new report published by Allied Market Research, titled, “Syphilis Testing Market,” The syphilis testing market was valued at $1.1 billion in 2020, and is estimated to reach $1.9 billion by 2030, growing at a CAGR of 5.6% from 2021 to 2030.
Drivers, Restraints, and Opportunities –
Increase in the occurrence of sexually transmitted disease including syphilis and technological advancements drive the growth of syphilis testing market. However, high proportion of health and economic burden for the developing countries due to Syphilis and avoidance and refraining from voluntary / CICT Syphilis testing hinder the uptake of diagnostic tests or testing volume, thus restraining the growth of the syphilis testing market. Moreover, rapid development in diagnostic kits, improved healthcare infrastructure, and availability of test kits are expected to create opportunities for market growth during the forecast period.
Access Sample Data & Findings:
https://www.alliedmarketresearch.com/request-sample/675
Syphilis is a sexually transmitted disease caused by the bacteria Treponema pallidum. Syphilis tests are used to diagnose and detect antibodies against the bacteria in a patient’s blood. There are various problems associated with syphilis such as male infertility, ectopic pregnancy, cervical cancer in women, and mortality from disease. Treponemal tests used to diagnose bacterial infections include Treponema pallidum particle agglutination (TP-PA) and fluorescent treponemal antibody (FTA-ABS). Non-treponemal tests are easy to perform and interpret, provide quick results, and are inexpensive. However, non-treponemal tests require laboratory equipment and trained personnel to perform and interpret test reactions. Non-treponemal tests include Rapid Plasma Reagin (RPR), which is a form of the Venereal Disease Research Laboratory (VDRL) test, and tests for specific antigens.
Major Key Players –
- Becton Dickinson And Company
- Hologic, Inc.
- Cepheid Inc.
- DiaSorin
- Abbott Laboratories
- Bio-Rad Laboratories
- Beckman Coulter Inc
- F. Hoffmann-La Roche
- Affymetrix, Inc
- Siemens healthcare
The laboratory testing segment held the lion’s share in 2020 –
Based on location of testing, the laboratory testing segment held the lion’s share in 2020, contributing to more than four-fifths of the global syphilis testing market, and is expected to continue its lead during the forecast period. However, thepoint of care (POC) testing segment is expected to witness the highest CAGR of 6.8% by 2030, due to increase in prevalence of syphilis infection, the laboratory test is cost efficient, convenient and confidential for use in hospitals & clinics.
North America, to lead the trail in terms of revenue –
By region, North America, garnered the major share in 2020, contributing to more than one-third of the global syphilis testing market and is expected to dominate the market during the forecast period. However, LAMEA region is expected grow at the fastest CAGR of 6.2% by 2030.
★ See What’s Inside This Report @
https://www.alliedmarketresearch.com/purchase-enquiry/675
Another key factors, such as implementation of screening program and increase in awareness about sex, lead to syphilis testing market growth. Hence, prevention and control of transmission of STDs remain of vital importance and of utmost priority across all regions. Such prevention and control of transmission of syphilis can be possible by early detection diagnostic testing.
About Us:
Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides end-to-end solutions along with information, education, advocacy, and networking resources to SMEs and early-stage start-ups to bring excellence to their processes. In addition, we offer a nurturing environment required to develop and grow businesses, including business planning; virtual support; market intelligence; acquiring resources; and getting direct access to finance, suppliers, and other experts to boost the growth of businesses and entrepreneurs.
Our bundled and hassle-free business support systems are customized to meet the needs of SME consultants and industry leaders. Moreover, our large network of skilled consultants and experts help start-ups get the business on a roll.
Contact:
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int’l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
[email protected]
